Axogen, Inc. Appoints John H. Johnson to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.
Revolutionizing the Science of Nerve Repair and Regeneration
Peripheral nerve damage is estimated to affect more than 20 million people in the United States, causing symptoms that range from mild discomfort to severe disability. Damage is often undiagnosed or untreated, and the current standard of care procedures can be associated with limitations that impact the quality of life. UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a company focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair, aims to address these issues and provide more efficient treatment options to patients.
UF’s Sid Martin Biotech Business Incubator Celebrates 25 Years
As one of the first biotech business incubators in the United States, UF Innovate | Sid Martin Biotech has paved the way to success for many startup companies. Sid Martin celebrates its 25th anniversary today and continues to have a timeless impact. “The 25th anniversary of Sid Martin is a testimonial to business incubation – […]
Axogen Recon Clinical Study Completes Target Enrollment of 220 Subjects
UF Innovate | Sid Martin Biotech alum AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced that its phase 3 pivotal RECONSM Clinical Study supporting its Biologics License Application (BLA) submission for Avance Nerve Graft has reached its enrollment target of 220 subjects. RECON […]
Axogen Announces New Seven-Year Financing Agreement With Oberland Capital
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced a financing agreement with Oberland Capital and provided preliminary, estimated revenue for the second quarter ended June 30, 2020. The financing agreement provides up to $75 million in […]
UF Innovate | Sid Martin Biotech Announces New Board of Advisors
UF Innovate | Sid Martin Biotech is pleased to announce a new board of advisors to provide mentorship for client companies at the business incubator, which is celebrating its 25th anniversary in 2020. The Advisory Board will further Sid Martin Biotech’s mission to facilitate the growth of its biotech companies. “In our continuing efforts to […]
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced preliminary unaudited fourth quarter and full-year 2019 revenue. “We delivered solid revenue growth in both the fourth quarter and the full year, and I am pleased with the […]
Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
UF startup and UF Innovate | Sid Martin Biotech graduate company Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, selected Jessica de Paz to ride on the 2020 Donate Life Rose Parade float that was featured in the annual Tournament of Roses® parade. The […]
Axogen Awarded Research Grant From the Advanced Regenerative Manufacturing Institute
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced it has been awarded a grant to research and develop an automated bioprocessing system for human tissue scaffolds. Axogen’s partnership with the Advanced Regenerative Manufacturing […]
Karen Zaderej, Chairman, CEO, and President of Axogen, Interviewed in Small-Cap Institute Podcast
Small-Cap Institute host Amanda Gerut interviews Karen Zaderej, chairman, CEO, and president of UF startup and UF Innovate | Sid Martin Biotech graduate company Axogen, a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves. Karen has been a part of Axogen since May 2006, serving as Vice President of Marketing and […]